Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467220 · ClinicalTrials.gov registry record · NA
Effect of Daily Calorie or Alternate-day Calorie Reductions on Risk for Cardiovascular Disease and Cancer
A NA study of Moderately Overweight Individuals, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT00467220 is a NA study of Moderately Overweight Individuals that has completed, run by University of California, San Francisco. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00467220, a NA study of Moderately Overweight Individuals, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine and compare the effects of alternate-day reductions in calorie intake or daily calorie restriction on the risk for cardiovascular disease and cancer.
Conditions Studied
Interventions
- BEHAVIORAL calorie restriction
Study Locations (1)
California
- San Francisco General Hospital - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2007-04 |
| Est. Completion | 2015-12-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00467220
The ClinicalTrials.gov registry entry for NCT00467220 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Moderately Overweight Individuals appearing as the primary indexed condition, and to 1 intervention - of which calorie restriction is the first listed.
NCT00467220 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00467220 about?
NCT00467220 is a clinical study titled "Effect of Daily Calorie or Alternate-day Calorie Reductions on Risk for Cardiovascular Disease and Cancer". The purpose of this study is to examine and compare the effects of alternate-day reductions in calorie intake or daily calorie restriction on the risk for cardiovascular disease and cancer.
What is the current status of trial NCT00467220?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2007-04. Estimated completion is 2015-12-17.
What conditions does trial NCT00467220 study?
This clinical trial studies the following conditions: Moderately Overweight Individuals.
What interventions are being tested in trial NCT00467220?
The interventions under investigation include: calorie restriction (BEHAVIORAL).
Who is sponsoring clinical trial NCT00467220?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00467220 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.